Endometrial Cell Function

The summary for the Endometrial Cell Function grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Endometrial Cell Function: The purpose of this program announcement is to solicit applications for support of basic pre-clinical research to enhance our understanding of etiology, and to improve treatment and prevention, of endometriosis. Special emphasis is placed on studies of cellular and molecular aspects of endometrial cell functions and their regulatory mechanisms. This PA is intended to increase our knowledge of: (1) how the sloughed endometrial fragments in menstrual flow become adhesive, invasive, and proliferate in ectopic sites; (2) what molecules are involved in adhesion, invasion, and proliferation of endometrial cells at ectopic sites; and (3) what function of ectopic endometrial tissues results in pain and other adverse effects including infertility.

Federal Grant Title:	Endometrial Cell Function
Federal Agency Name:	National Institutes of Health
Grant Categories:	Income Security and Social Services Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PA-04-056
Type of Funding:	Grant
CFDA Numbers:	93.865
CFDA Descriptions:	National Institute of Child Health and Human Development Extramural Research
Current Application Deadline:	No deadline provided
Original Application Deadline:	Multiple Receipt Dates - See Link to Full Announce
Posted Date:	Feb 09, 2004
Creation Date:	Jan 09, 2007
Archive Date:	Feb 03, 2007
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Independent school districts Special district governments State governments Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) County governments Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Small businesses For profit organizations other than small businesses Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized)
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [email protected] NIH OER Webmaster
Similar Government Grants: • Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allo...; • National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50 C...; • Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescen...; • Chemical Screening and Optimization Facility (X01 Clinical Trial Not Allowed); • Biological Testing Facility (X01 Clinical Trial Not Allowed); • Phase II Small Business Technology Transfer Renewal Awards for Device Assessment or Precli...; • Phase II Small Business Innovation Research Renewal Awards for Device Assessment or Precli...; • Reproductive Genetics and Epigenetics
More Grants from the National Institutes of Health: • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...; • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...; • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional); • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...